Clinical Rheumatology

, Volume 12, Issue 2, pp 186–191

Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial

  • M. Grönblad
  • J. Nykänen
  • Y. Konttinen
  • E. Järvinen
  • T. Helve
Originals

Summary

Thirty-three patients fulfilling the diagnostic criteria for primary fibromyalgia completed an eight-week double-blind treatment trial with the drug zopiclone. Of outcome measures studied a score expressing subjective sleep quality showed improvement in more than ninety percent of zopiclone patients at 4 weeks and nearly eighty percent at 8 weeks, but similar improvement was also reported by more than sixty percent of the patients on placebo. Patient self-assessment of a treatment effect also showed an advantage for zopiclone, with most patients in the placebo group considering their state as unchanged at 8 weeks. According to examiner assessment, however, half the patients in both groups showed improvement at 8 weeks. For other assessment variables, e.g. dolorimeter assessment of widespread tenderness, visual analogue scales and pain drawings for pain and other subjective feelings of discomfort, the effects of zopiclone treatment were at the same level as those of placebo.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moldofsky, H., Scarisbrick, P., England, R., Smythe, H. Musculoskeletal symptoms and nonREM sleep disturbance in patients with “fibrositis” syndrome and healthy subjects. Psychosom Med 1975, 37, 341–351.PubMedGoogle Scholar
  2. 2.
    Yunus, M.B., Masi, A.T., Calabro, J.J., Miller, K.A., Feigenbaum, S.L. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981, 11, 151–171.PubMedGoogle Scholar
  3. 3.
    Wolfe, F., Smythe, H.A., Yunus, M.B. et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of a multicenter criteria committee. Arthritis Rheum 1990, 33, 160–172.PubMedGoogle Scholar
  4. 4.
    Nicholson, A.N., Stone, B.M. Zopiclone: sleep and performance studies in healthy man. Pharmacology 1983, 27(S2), 92–98.PubMedGoogle Scholar
  5. 5.
    Drewes, A.M., Andreasen, A., Jennum, P., Nielsen, K.D. Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol 1991, 20, 288–293.PubMedGoogle Scholar
  6. 6.
    Wolfe, F. Fibromyalgia. Rheum Dis Clin N Am 1990, 16, 681–698.Google Scholar
  7. 7.
    Campbell, S.M. Is the tender point concept valid? Am J Med 1986, 81(3A), 33–37.Google Scholar
  8. 8.
    Huskisson, E.C. Measurement of pain. J Rheumatol 1982, 9, 768–769.PubMedGoogle Scholar
  9. 9.
    Grönblad, M., Lukinmaa, A., Konttinen, Y.T. Chronic low-back pain: interrelation of repeated measures for pain and disability. Scand J Rehabil Med 1990, 22, 73–77.PubMedGoogle Scholar
  10. 10.
    Carette, S., McCain, G.A., Bell, D.A. et al. Evaluation of amitriptyline in primary fibrositis. Arthritis Rheum 1986, 29, 655–659.PubMedGoogle Scholar
  11. 11.
    Jaeschke, R., Adachi, J., Guyatt, G., Keller, J., Wong, B. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol 1991, 18, 447–451.PubMedGoogle Scholar
  12. 12.
    Reynolds, W.J., Moldofsky, H., Saskin, P., Lue, F.A. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol 1991, 18, 452–454.PubMedGoogle Scholar
  13. 13.
    Smythe, H.A., Sheon, R.P. Fibrositis/fibromyalgia: a difference of opinion. Bull Rheum Dis 1990, 39, 1–8.Google Scholar
  14. 14.
    Russell, I.J., Fletcher, E.M., Michalek, J.E., McBroom, P.C., Hester, G.G. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. Arthritis Rheum 1991, 34, 552–560.PubMedGoogle Scholar
  15. 15.
    Stratz, T., Mennet, P., Beun, H.-P., Muller, W. Blockierung der S2-Rezeptoren — Ein neues Behandlungsprinzip der generalisierten Tendomyopathie (Fibromyalgie)? Z Rheumatol 1991, 50, 21–22.PubMedGoogle Scholar
  16. 16.
    Mamelak, M., Scima, A., Price, V. Effects of zopiclone on the sleep of chronic insomniacs. Pharmacology 1983, 27(S2), 156–165.PubMedGoogle Scholar
  17. 17.
    Simms, R.W., Felson, D.T., Goldenberg, D.L. Development of preliminary criteria for response to treatment in fibromyalgia syndrome. J Rheumatol 1991, 18, 1558–1563.PubMedGoogle Scholar

Copyright information

© Clinical Rheumatology 1993

Authors and Affiliations

  • M. Grönblad
    • 4
  • J. Nykänen
    • 4
  • Y. Konttinen
    • 1
  • E. Järvinen
    • 2
  • T. Helve
    • 3
  1. 1.Finnish AcademyHelsinki
  2. 2.Institute of Occupational HealthHelsinki
  3. 3.Department of Internal MedicineKivelä City HospitalHelsinkiFinland
  4. 4.Department of Physical Medicine and RehabilitationHelsinki University HospitalHelsinkiFinland

Personalised recommendations